Overview

89Zr-bevacizumab PET Scan in Patients With Relapsing Multiple Myeloma

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see whether 89Zr-bevacizumab PET scanning is feasible in relapsing multiple myeloma patients.
Phase:
N/A
Details
Lead Sponsor:
University Medical Center Groningen
Treatments:
89Zr-bevacizumab
Bevacizumab